Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats

被引:11
作者
Tsai, TH
Chang, CH
Lin, LC
机构
[1] Natl Res Inst Chinese Med, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan
[3] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan
关键词
Caffeine; Evodia rutaecarpa; Rutaceae; microdialysis; pharmacokinetics; rutaecarpine; traditional Chinese medicine;
D O I
10.1055/s-2005-871270
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
To assess possible herb-drug interactions, rutaecarpine (an herbal ingredient of Evodia rutaecarpa; 25 mg/kg/day, p.o.), the ethanol extract of Evodia rutaecarpa (1 g/kg/day, p.o.), and an herbal preparation of Evodia rutaecarpa (Wu-Chu-Yu-Tang; 1 g/kg/day) were individually pretreated daily for three consecutive days in rats and on the fourth day caffeine was administered (2 mg/kg, i.v.). Caffeine concentrations in blood, brain and bile were concurrently measured by microdialysis coupled to a liquid chromatographic system. Pharmacokinetic data were calculated by a non-compartmental model. The results indicate that the caffeine crosses the blood-brain barrier and goes through hepatobiliary excretion. The caffeine level was significantly decreased by the pretreatment of rutaecarpine, the extract of Evodia rutaecarpa and herbal preparation Wu-Chu-Yu-Tang. This finding should be very important whenever herb-drug interactions would be possible for a herbal remedy.
引用
收藏
页码:640 / 645
页数:6
相关论文
共 23 条
[1]  
ASAHINA Y, 1915, J PHARM SOC JPN, V35, P293
[2]   INDUCTION OF HEPATIC CYP1A2 BY THE ORAL-ADMINISTRATION OF CAFFEINE TO RATS - LACK OF ASSOCIATION WITH THE AH LOCUS [J].
AYALOGU, EO ;
SNELLING, J ;
LEWIS, DFV ;
TALWAR, S ;
CLIFFORD, MN ;
IOANNIDES, C .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1272 (02) :89-94
[3]  
BEACH CA, 1985, J PHARMACOL EXP THER, V233, P18
[4]   CAFFEINE INCREASES ITS OWN METABOLISM THROUGH CYTOCHROME P4501A INDUCTION IN RATS [J].
BERTHOU, F ;
GOASDUFF, T ;
DREANO, Y ;
MENEZ, JF .
LIFE SCIENCES, 1995, 57 (06) :541-549
[5]  
Chen LS, 1996, DRUG METAB DISPOS, V24, P529
[6]   Biotransformation of caffeine by cDNA expressed human cytochromes P-450 [J].
Ha, HR ;
Chen, J ;
Krahenbuhl, S ;
Follath, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 49 (04) :309-315
[7]   EXCRETION OF CAFFEINE AND ITS PRIMARY DEGRADATION PRODUCTS INTO BILE [J].
HOLSTEGE, A ;
KURZ, M ;
WEINBECK, M ;
GEROK, W .
JOURNAL OF HEPATOLOGY, 1993, 17 (01) :67-73
[8]  
KANO Y, 1991, CHEM PHARM BULL, V39, P690, DOI 10.1248/cpb.39.690
[9]   INVITRO AND INVIVO EVALUATION OF THE TISSUE-TO-BLOOD PARTITION-COEFFICIENT FOR PHYSIOLOGICAL PHARMACOKINETIC MODELS [J].
LIN, JH ;
SUGIYAMA, Y ;
AWAZU, S ;
HANANO, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (06) :637-647
[10]  
MCCALL AL, 1982, LIFE SCI, V31, P709